Results

Total Results: 1,881 records

Showing results for "group".

21. Multidisciplinary Postacute Rehabilitation for Moderate to Severe Traumatic Brain Injury in AdultsBrain Injury in Adults Surveillance Report 08082016 CCKK CC final clean (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/traumatic-brain-injury-rehabilitation-surveillance-160902.pdf
    May 29, 2025 - $This$group$ also$cited$the$utility$of$this$measure$in$evaluating$progress$in$rehabilitation. … $ Not$postacute$intervention$ •$ Impairment"specific$intervention$ Comparison$ •$ No$comparison$group … $ •$ Not$relevant$comparison$(eg,$comparison$group$receives$same$treatment$at$the$same$ time$ Outcome … electronic$cognitive$aid$in$patients$with$acquired$brain$injury:$a$multicentre$randomised$ parallel"group … $Group$Therapy$Use$and$Its$Impact$on$the$ Outcomes$of$Inpatient$Rehabilitation$After$Traumatic$Brain

22. Type-2-Diabetes-Medications-Update Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_surveillance.pdf
    December 31, 2013 - A week 80 decrease of 3.37 kg in the metformin group and an increase of 1.42 kg in the Avandamet group … Hypoglycemia was reported at 7% in the sitagliptin group and 22% in the glimepiride group (p < 0.001 … and 0.9% (−1.7, 3.5) in the glimepiride group, resulting in a between group difference of 3.5% (0.6 … and 2.1% (−1.7, 5.9) in the glimepiride group, resulting in a between-group difference of −6.1% (−10.4 … versus 24 (5%) in the canagliflozin 100 mg group and 26 (5%) in the 300 mg group.

23. Rapid Response_The Association Between Outcomes and Dental Services in Persons With Autoimmune Disease Treated With Biologics and Other Immunosuppressants: A Rapid Response Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/autoimmune-disease-rapid-research.pdf
    November 01, 2024 - % Change in Treatment Group Intra-Group % Change in Control Group Summary of Statistically … % Change in Treatment Group Intra-Group % Change in Control Group Summary of Statistically … % Change in Treatment Group Intra-Group % Change in Control Group Summary of Statistically … % Change in Treatment Group Intra-Group % Change in Control Group Summary of Statistically … % Change in Treatment Group Intra-Group % Change in Control Group Summary of Statistically

24. Erythropoiesis-Stimulating-Agents-Utilization Research (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/erythropoiesis-stimulating-agents-utilization_research.pdf
    February 01, 2011 - We further examined the proportion of beneficiaries in each aforemen- tioned group with ESA use. … to 22 percent, the inter- mittent KD group fell from 6 percent to 4 percent, and the non-KD group fell … During the study period, the size of the cancer and dialysis group remained stable, the cancer only group … ESAs, while the cancer and predialysis group grew from 9 percent to 27 percent. … The cancer and intermittent KD group grew from 5 percent to 9 percent, and the cancer only group

25. Cannabis-App-F1-F4-Tables-Surveillance-Report-2 0 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f1-f4-tables-surveillance-report-2_0_0.xlsx
    May 29, 2025 - Mean ∆ Intervention D, N Analyzed for Between Group Mean ∆ Between Group Mean Δ Type Between Group … Mean Δ Between Group Δ Variance Between Group Δ 95% CI Lower Limit Between Group Δ 95% CI Upper Limit … Mean ∆ Intervention D, N Analyzed for Between Group Mean ∆ Between Group Mean Δ Type Between Group … Mean Δ Between Group Δ Variance Between Group Δ 95% CI Lower Limit Between Group Δ 95% CI Upper Limit … Mean ∆ Intervention D, N Analyzed for Between Group Mean ∆ Between Group Mean Δ Type Between Group

26. Reduction in Medication Use after Bariatric Surgery (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/bariatric-surgery_research.pdf
    June 01, 2010 - Comparison group without surgery. … group was older. … Medication use in the bariatric surgery group and the matched non-surgical group of patients likely … Non-surgical Group Surgical Group Non-surgical Group Diabetes Diabetic Patients 1.07 [1.02 … Non-surgical Group Surgical Group Non-surgical Group Lipid-lowering Diabetic Patients 0.34

27. Autism Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism_surveillance.pdf
    October 01, 2012 - imitation and spontaneous imitation than a control group (Ingersall, 2010). … Pivotal response group treatment program for parents of children with autism. … psychotherapy or encounter group therapy or marathon group therapy or therapeutic community … No signficant main effect was found for group. … skills group 55 children aged 8 to 12 with high functioning autism Setting: Group Intensity: 15

28. Arcia-notes-Teresa (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/arcia-presentation.pdf
    May 29, 2025 - And  we started  to group   our infographics according to those tasks.   8 S o for example … Then  after iterations with focus group  participants, we came up with  the one on   the right … I had   focus group  attendees tell me that Maria  was active. … It is a randomized control trial in which each group serves as the other group's control. … Maria  is in Group A.

29. Enhanced Functionality for the Distributed Research Network Pilot (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/distributed-network-expansion_research.pdf
    April 01, 2012 - Group list form Group names will be presented as hyperlinks. … Clicking on the group name will bring up the Group Detail screen for the selected group. … The New Group button will bring up the Group Detail screen for creating a new group. … The Group Detail form presents the details of the group, as follows: Figure 13. … Group detail form fields Field Database Table/Column Group name Group.GroupName Not In Group Initially

30. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_executive.pdf
    March 01, 2011 - We recommend that studies consistently report between-group comparisons of changes from baseline, as … Moderate Rosiglitazone increased HDL to a lesser extent than did pioglitazone (pooled between-group … Moderate Pioglitazone increased HDL to a greater extent than did sulfonylureas (pooled between-group … The range of rates for non-fatal ischemic heart disease for the comparison group, metformin, ranged … The range of rates for mild to moderate hypoglycemia in the metformin group was 0 to 17.7%, with a

31. Ch 5-User-Guide-To-Ocer 130129 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/ch_5-user-guide-to-ocer_130129.pdf
    January 01, 2012 - Defining the appropriate dose, intensity of treatment, and exposure window for each comparator group … ) and those without A (comparison group). … select time zero for the no-treatment group. … and comparison group. … Therefore, researchers first should assess and report the dose in each group.

32. HIGH PLAINS RESEARCH NETWORK (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/norman.pdf
    May 29, 2025 - Our group is made up of all of the unusual suspects. … Because I want you to understand that our group is not like a focus group. … Even the young group will get into it. … NORMAN: It's our high school members of our group. … A few years later they would come to us and say, "Well, I have a group.

33. White Paper_Living Systematic Reviews: Examining Excluded Full-Text Articles To Better Understand the Evidence Base on Plant-Based Treatments for Chronic Pain (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/living-systematic-reviews-full-text-articles-white-paper.pdf
    January 01, 2024 - 12 studies evaluated an ineligible intervention, and 33 studies evaluated did not have a comparison group … different doses or frequencies of use and the others were uncontrolled studies (i.e., no comparison group … Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group … A randomized, double-blind, placebo- controlled, parallel-group, enriched-design study of Nabiximols … A randomized, double-blind, placebo- controlled, parallel-group, enriched-design study of nabiximols

34. Outcomes in COPD patients treated with theophylline (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/decide16final-mortality-risk-in-copd-pts-using-theophylline.pdf
    December 01, 2009 - For example, the ICS+LABA group was compared to the ICS+LABA+THEO group. … Baseline characteristics for each group Group 1 Group 2 Group 3 IPRA + THEO p-value ICS … Baseline characteristics for each group Group 4 Group 5 Group 6 LABA + IPRA + THEO p-value … Medication use for each group Group 1 Group 2 Group 3 IPRA + THEO p-value ICS + IPRA + THEO … Medication use for each group Group 4 Group 5 Group 6 LABA+IPRA + THEO p-value ICS + THEO

35. Outcomes in COPD patients treated with theophylline (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/copd-management_research.pdf
    December 01, 2009 - For example, the ICS+LABA group was compared to the ICS+LABA+THEO group. … Baseline characteristics for each group Group 1 Group 2 Group 3 IPRA + THEO p-value ICS … Baseline characteristics for each group Group 4 Group 5 Group 6 LABA + IPRA + THEO p-value … Medication use for each group Group 1 Group 2 Group 3 IPRA + THEO p-value ICS + IPRA + THEO … Medication use for each group Group 4 Group 5 Group 6 LABA+IPRA + THEO p-value ICS + THEO

36. A Randomized Trial of Epidural Glucocorticoid Injections for Spinal Stenosis: A Brief Summary of Findings for Clinicians (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/glucocorticoid-injections_clinician.pdf
    June 01, 2016 - group. … KEY FINDINGS »» At 6 weeks after injection, patients in both the glucocorticoids-plus-lidocaine group … and the lidocaine-alone group had improved pain-related functional disability and leg pain intensity … than in the lidocaine- alone group (0.29 vs. 0.17 events per patient; p=0.02). … and excessive pain in the lidocaine-alone group. »» Among participants receiving glucocor- ticoids

37. Cannabis-2022-Update-Surv-Rep-1-App-F1-4 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F1-4.xlsx
    January 01, 2022 - Mean ∆ Intervention D, N Analyzed for Between Group Mean ∆ Between Group Mean Δ Type Between Group … Mean Δ Between Group Δ Variance Between Group Δ 95% CI Lower Limit Between Group Δ 95% CI Upper Limit … Mean ∆ Intervention D, N Analyzed for Between Group Mean ∆ Between Group Mean Δ Type Between Group … Mean Δ Between Group Δ Variance Between Group Δ 95% CI Lower Limit Between Group Δ 95% CI Upper Limit … Mean ∆ Intervention D, N Analyzed for Between Group Mean ∆ Between Group Mean Δ Type Between Group

38. Cer-250-Cannabis-Tables-E1-E4-2022-Update 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-tables-e1-e4-2022-update_0.xlsx
    January 01, 2022 - Mean ∆ Intervention D, N Analyzed for Between Group Mean ∆ Between Group Mean Δ Type Between Group … Mean Δ Between Group Δ Variance Between Group Δ 95% CI Lower Limit Between Group Δ 95% CI Upper Limit … Mean ∆ Intervention D, N Analyzed for Between Group Mean ∆ Between Group Mean Δ Type Between Group … Mean Δ Between Group Δ Variance Between Group Δ 95% CI Lower Limit Between Group Δ 95% CI Upper Limit … Mean ∆ Intervention D, N Analyzed for Between Group Mean ∆ Between Group Mean Δ Type Between Group

39. Choice-Of-Mean White-Paper (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/choice-of-mean_white-paper.pdf
    April 01, 2015 - Group #2) Number of Studies (N) Group #1 and Group #2 Total Sample Size (Min–Max) Baseline … Group #2) Number of Studies (N) Group #1 and Group #2 Total Sample Size (Min-Max) Baseline … Group #2) Number of Studies (N) Group #1 and Group #2 Total Sample Size (Min-Max) Baseline … Group #2) Number of Studies (N) Group #1 and Group #2 Total Sample Size (Min-Max) Baseline … Group #2) Number of Studies (N) Group #1 and Group #2 Total Sample Size (Min-Max) Baseline

40. Developing and Piloting a Tool To Create Dot Plots To Summarize Pooled Data for Multiple Outcomes in Systematic Reviews (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/dot-plots-methods.pdf
    October 01, 2021 - The dot plot also shows the number of adverse events in each group. … trt_N Total N of treatment group ctrl_n Number of events in control group ctrl_N Total N of control … group RR Pooled risk ratio from meta-analysis Cil lower bound of 95% CI of RR Ciu upper bound of … trt_N Total N of treatment group ctrl_n Number of events in control group ctrl_N Total N of control … ctrl_bl_mean Weighted mean at baseline of treatment group trt_N Total N of treatment group ctrl_N